627 related articles for article (PubMed ID: 27435998)
1. Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis.
Pericolini E; Gabrielli E; Ballet N; Sabbatini S; Roselletti E; Cayzeele Decherf A; Pélerin F; Luciano E; Perito S; Jüsten P; Vecchiarelli A
Virulence; 2017 Jan; 8(1):74-90. PubMed ID: 27435998
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis.
Gabrielli E; Pericolini E; Ballet N; Roselletti E; Sabbatini S; Mosci P; Decherf AC; Pélerin F; Perito S; Jüsten P; Vecchiarelli A
Benef Microbes; 2018 Feb; 9(2):219-230. PubMed ID: 29380641
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
4. The Absence of N-Acetyl-D-glucosamine Causes Attenuation of Virulence of Candida albicans upon Interaction with Vaginal Epithelial Cells In Vitro.
Manczinger M; Bocsik A; Kocsis GF; Vörös A; Hegedűs Z; Ördögh L; Kondorosi É; Marton A; Vízler C; Tubak V; Deli M; Kemény L; Nagy I; Lakatos L
Biomed Res Int; 2015; 2015():398045. PubMed ID: 26366412
[TBL] [Abstract][Full Text] [Related]
5. Recovery of
Decherf A; Dehay E; Boyer M; Clément-Ziza M; Rodriguez B; Legrain-Raspaud S
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722250
[TBL] [Abstract][Full Text] [Related]
6. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S
Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624
[TBL] [Abstract][Full Text] [Related]
7. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.
Sun Z; Ge X; Qiu B; Xiang Z; Jiang C; Wu J; Li Y
Front Cell Infect Microbiol; 2023; 13():1123026. PubMed ID: 36816582
[TBL] [Abstract][Full Text] [Related]
8. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
[TBL] [Abstract][Full Text] [Related]
10. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence.
Trumbore DJ; Sobel JD
Obstet Gynecol; 1986 Jun; 67(6):810-2. PubMed ID: 3517722
[TBL] [Abstract][Full Text] [Related]
11. In vitro probiotic properties of vaginal Lactobacillus fermentum MG901 and Lactobacillus plantarum MG989 against Candida albicans.
Kang CH; Kim Y; Han SH; Kim JS; Paek NS; So JS
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():232-237. PubMed ID: 30014929
[TBL] [Abstract][Full Text] [Related]
12. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
[TBL] [Abstract][Full Text] [Related]
13. Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis.
Miao J; Regan J; Cai C; Palmer GE; Williams DL; Kruppa MD; Peters BM
mBio; 2023 Apr; 14(2):e0004623. PubMed ID: 36840583
[TBL] [Abstract][Full Text] [Related]
14. Candida and its dual lifestyle as a commensal and a pathogen.
Cauchie M; Desmet S; Lagrou K
Res Microbiol; 2017; 168(9-10):802-810. PubMed ID: 28263903
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for oral and vulvovaginal candidiasis: A review.
Shenoy A; Gottlieb A
Dermatol Ther; 2019 Jul; 32(4):e12970. PubMed ID: 31112355
[TBL] [Abstract][Full Text] [Related]
16. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
17. Cell-free supernatants of probiotic consortia impede hyphal formation and disperse biofilms of vulvovaginal candidiasis causing Candida in an ex-vivo model.
Kumar SAS; Krishnan D; Jothipandiyan S; Durai R; Hari BNV; Nithyanand P
Antonie Van Leeuwenhoek; 2024 Feb; 117(1):37. PubMed ID: 38367023
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of vaginal candidiasis: studies with a mutant which has reduced ability to adhere in vitro.
Lehrer N; Segal E; Cihlar RL; Calderone RA
J Med Vet Mycol; 1986 Apr; 24(2):127-31. PubMed ID: 3522840
[TBL] [Abstract][Full Text] [Related]
19. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
Mendling W; Brasch J; ; ; ;
Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
[TBL] [Abstract][Full Text] [Related]
20. Effect of progesterone on Candida albicans vaginal pathogenicity.
Alves CT; Silva S; Pereira L; Williams DW; Azeredo J; Henriques M
Int J Med Microbiol; 2014 Nov; 304(8):1011-7. PubMed ID: 25183575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
